argenx to Present at Upcoming Investor Conferences

On February 26, 2024 argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, reported that members of the management team will participate in the following investor conferences in March (Press release, argenx, FEB 26, 2024, View Source [SID1234640467]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 44th Annual Health Care Conference. Fireside chat on Monday, March 4, 2024 at 11:10 a.m. ET in Boston, MA.

Leerink Global Biopharma Conference. Fireside chat on Monday, March 11, 2024 at 2:40 p.m. ET in Miami, FL.

Barclays Global Healthcare Conference. Fireside chat on Tuesday, March 12, 2024 at 3:35 p.m. ET in Miami, FL.

Additional information regarding these events will be available on the Investors section of the argenx website at argenx.com/investors.